AbbVie, Roche combo treatment meets main goal of leukemia trial - Nano News Online

Wednesday, October 31, 2018

AbbVie, Roche combo treatment meets main goal of leukemia trial

AbbVie Inc and Roche Holding AG said on Wednesday their immunotherapy delayed the progression of a type of blood and bone marrow cancer when used in combination with the Swiss drugmaker's cancer drug in a late-stage trial.


from Reuters: Health News https://ift.tt/2ADJhvU

No comments:

Post a Comment